Loading
Latest filing published 18 Aug 2025 for Oncolytics Biotech Inc..
No signal scores available.
Amy Levin discloses dealings in Oncolytics Biotech Inc. to SEDI. We count 3 filings; the first trade dates from 9 December 2024 and the latest from 18 August 2025.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 18 August 2025: an option exercise, in Oncolytics Biotech Inc. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.